Cite

HARVARD Citation

    Nishimoto, N. et al. (2014). Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study. Modern rheumatology. 24 (1), pp. 17-25. [Online]. 
  
Back to record